Reconsidering the Benefits of Osteoporosis Treatment: The Case of Bisphosphonates

Am J Med. 2024 Jun;137(6):476-478. doi: 10.1016/j.amjmed.2024.02.012. Epub 2024 Feb 22.

Author

Christopher W Goodman¹

Affiliation

¹ Department of Internal Medicine, University of South Carolina School of Medicine, Columbia. Electronic address: christopher.goodman@uscmed.sc.edu.

PMID: 38401675
DOI: 10.1016/j.amjmed.2024.02.012

No abstract available

Publication types

Editorial

MeSH terms

Bone Density Conservation Agents* / therapeutic use
Diphosphonates* / therapeutic use
Female
Humans
Osteoporosis* / drug therapy
Osteoporotic Fractures / prevention & control

Substances

Diphosphonates
Bone Density Conservation Agents